Background: Objective and time-effective tools are needed to identify motor-cognitive impairment and facilitate early intervention. Objective: We examined the feasibility, accuracy, and reliability of an instrumented trail-making task (iTMT) using a wearable sensor to identify motor-cognitive impairment among older adults. Methods: Thirty subjects (age = 82.2 + 6.1 years, body mass index = 25.7 + 4.8, female = 43.3%) in 3 age-matched groups, 11 healthy, 10 with amnestic mild cognitive impairment (aMCI), and 9 with Alzheimer disease (AD), were recruited. Subjects completed iTMT, using a wearable sensor attached to the leg, which translates the motion of the ankle into a human-machine interface. iTMT tests included reaching to 5 indexed circles on a computer screen by moving the ankle-joint while standing. iTMT was quantified by the time required to reach all circles in the correct sequence. Three iTMT tests were designed, including numbers (1-5) positioned in a fixed (iTMTfixed) or random (iTMTrandom) order, or numbers (1-3) and letters (A and B) positioned in random order (iTMTnumber-letter). Each test was repeated twice to examine test-retest reliability. In addition, the conventional trail-making task (TMT A and B), Montreal Cognitive Assessment (MoCA), and dual-task cost (DTC: gait-speed difference between walking alone and walking while counting backward) were used as references. Re sults: Good-to-excellent reliability was achieved for all iTMT tests (intraclass correlation [ICC] = 0.742-0.836). Between-group difference was more pronounced, when using iTMTnumber-letter, with average completion time of 26.3 ± 12.4, 37.8 ± 14.1, and 61.8 ± 34.1 s, respectively, for healthy, aMCI, and AD groups (p = 0.006). Pairwise comparison suggested strong effect sizes between AD and healthy (Cohen's d = 1.384, p = 0.001) and between aMCI and AD (d = 0.923, p = 0.028). Significant correlation was observed when comparing iTMTnumber-letter with MoCA (r = -0.598, p = 0.001), TMT A (r = 0.519, p = 0.006), TMT B (r = 0.666, p < 0.001), and DTC (r = 0.713, p < 0.001). Conclusion: This study demonstrated proof of concept of a simple, safe, and practical iTMT system with promising results to identify cognitive and dual-task ability impairment among older adults, including those with aMCI and AD. Future studies need to confirm these observations in larger samples, as well as iTMT's ability to track motor-cognitive decline over time.

1.
Bradford A, Kunik ME, Schulz P, Williams SP, Singh H: Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord 2009;23:306-314.
2.
Bahureksa L, Najafi B, Saleh A, Sabbagh M, Coon D, Mohler MJ, Schwenk M: The impact of mild cognitive impairment on gait and balance: a systematic review and meta-analysis of studies using instrumented assessment. Gerontology 2016, Epub ahead of print.
3.
Alzheimer's Association: 2015 Alzheimer's disease facts and figures. Alzheimer's and Dementia. J Alzheimers Assoc 2015;11:332-384.
4.
Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB: Prevalence of dementia in the united states: the aging, demographics, and memory study. Neuroepidemiology 2007;29:125-132.
5.
Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB: Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 2008;148:427-434.
6.
van Gelder BM, Tijhuis MA, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D: Physical activity in relation to cognitive decline in elderly men: the FINE study. Neurology 2004;63:2316-2321.
7.
Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA; Alzheimer's Disease Cooperative Study: Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: The Alzheimer's Disease Cooperative Study Cognitive Function Instrument. JAMA Neurol 2015;72:446-454.
8.
Moise P, Schwarzinger M, Um M-Y; Dementia Experts' Group: Dementia Care in 9 OECD Countries: A Comparative Analysis. OECD Health Working Papers No 13. Organisation for Economic Co-operation and Development, Paris, 2004, vol 13.
9.
Standridge JB: Pharmacotherapeutic approaches to the prevention of Alzheimer's disease. Am J Geriatr Pharmacother 2004;2:119-132.
10.
Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R: A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 2012;29:639-658.
11.
Iliffe S, Robinson L, Brayne C, Goodman C, Rait G, Manthorpe J, Ashley P; DeNDRoN Primary Care Clinical Studies Group: Primary care and dementia. 1. Diagnosis, screening and disclosure. Int J Geriatr Psychiatry 2009;24:895-901.
12.
Alzheimer's Association: 2015 Alzheimer's disease facts and figures: Alzheimers Dement 2015;11:332.
13.
Cockrell JR, Folstein MF: Mini-mental state examination. Princ Pract Geriatr Psychiatry 2002;24:140-141.
14.
Najafi B, Helbostad JL, Moe-Nilssen R, Zijlstra W, Aminian K: Does walking strategy in older people change as a function of walking distance? Gait Posture 2009;29:261-266.
15.
Plummer P, Grewal G, Najafi B, Ballard A: Instructions and skill level influence reliability of dual-task performance in young adults. Gait Posture 2015;41:964-967.
16.
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
17.
Schwenk M, Howe C, Saleh A, Mohler J, Grewal G, Armstrong D, Najafi B: Frailty and technology: a systematic review of gait analysis in those with frailty. Gerontology 2014;60:79-89.
18.
Grewal GS, Schwenk M, Lee-Eng J, Parvaneh S, Bharara M, Menzies RA, Talal TK, Armstrong DG, Najafi B: Sensor-based interactive balance training with visual joint movement feedback for improving postural stability in diabetics with peripheral neuropathy: a randomized controlled trial. Gerontology 2015;61:567-574.
19.
Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B: Interactive sensor-based balance training in older cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 2016;62:553-563.
20.
Najafi B, Armstrong DG, Mohler J: Novel wearable technology for assessing spontaneous daily physical activity and risk of falling in older adults with diabetes. J Diabetes Sci Technol 2013;7:1147-1160.
21.
Toosizadeh N, Joseph B, Heusser MR, Orouji Jokar T, Mohler J, Phelan HA, Najafi B: Assessing upper-extremity motion: an innovative, objective method to identify frailty in older bed-bound trauma patients. J Am Coll Surg 2016;223:240-248.
22.
Taylor-Piliae RE, Mohler MJ, Najafi B, Coull BM: Objective fall risk detection in stroke survivors using wearable sensor technology: a feasibility study. Top Stroke Rehabil 2016;23:393-399.
23.
Mohler MJ, Wendel CS, Taylor-Piliae RE, Toosizadeh N, Najafi B: Motor performance and physical activity as predictors of prospective falls in community-dwelling older adults by frailty level: application of wearable technology. Gerontology 2016;62:654-664.
24.
Grewal G, Sayeed R, Yeschek S, Menzies RA, Talal TK, Lavery LA, Armstrong DG, Najafi B: Virtualizing the assessment: a novel pragmatic paradigm to evaluate lower extremity joint perception in diabetes. Gerontology 2012;58:463-471.
25.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R: The diagnosis of dementia due to Alzheimer's disease: recommendations from The National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
26.
Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
27.
Orme JG, Reis J, Herz EJ: Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) Scale. J Clin Psychol 1986;42:28-33.
28.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-M156.
29.
Tombaugh TN: Trail making test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203-214.
30.
Bowie CR, Harvey PD: Administration and interpretation of the trail making test. Nat Protoc 2006;1:2277-2281.
31.
Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ: Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203-214.
32.
Grewal G, Sayeed R, Yeschek S, Menzies RA, Talal TK, Lavery LA, Armstrong DG, Najafi B: Virtualizing the assessment: a novel pragmatic paradigm to evaluate lower extremity joint perception in diabetes. Gerontology 2012;58:463-471.
33.
Gerling KM, Schild J, Masuch M: Exergaming for elderly: analyzing player experience and performance. Mensch and Computer 2011: 11 Fachübergreifende Konferenz für Interaktive und Kooperative Medien. Munich, Oldenbourg Verlag, 2011, p 401.
34.
Menz HB, Latt MD, Tiedemann A, Mun San Kwan M, Lord SR: Reliability of the GAITRite walkway system for the quantification of temporo-spatial parameters of gait in young and older people. Gait Posture 2004;20:20-25.
35.
Ellis P: Thresholds for Interpreting Effect Sizes. Hong Kong, Hong Kong Polytechnic University, 2009.
36.
Montero-Odasso M, Oteng-Amoako A, Speechley M, Gopaul K, Beauchet O, Annweiler C, Muir-Hunter SW: The motor signature of mild cognitive impairment: results from the Gait and Brain Study. J Gerontol A Biol Sci Med Sci 2014;69:1415-1421.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.